Source:http://linkedlifedata.com/resource/pubmed/id/16516225
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2006-3-14
|
pubmed:abstractText |
Identification of key factors mediating the differentiation of naïve CD4(+) T helper cells into Th1 and Th2 subsets is important for understanding the molecular mechanisms of the development of autoimmune diseases as well as asthma and allergy. Functional importance of a given gene in the initiation of human T helper cell differentiation has been hard to study due to the difficulty in transfecting primary resting human T lymphocytes. In this study we have successfully transfected human primary CD4(+) T helper cells using Amaxa's Nucleofection technology. To overcome the background caused by untransfected cells, we have developed a system for enriching nucleofected unstimulated human primary T helper cells that express the gene of interest. This is achieved by introducing a plasmid construct containing a bicistronic unit coding for a truncated mouse MHC class l H-2K(k) cell surface marker followed by selection of H-2K(k) positive cells using antibody coated beads. We demonstrate that the nucleofected and enriched H-2K(k) positive T helper cells differentiate into Th1 and Th2 cells as well as the non-transfected control cells. We also show that by using this novel method, introduction of an shRNA targeting Stat6, a key molecule driving the Th2 cell development, results in impaired Th2 cell differentiation, as expected. The method described here, enables fast and feasible preparation of highly pure transfected primary CD4(+) T cell cultures ideal for studying the influence of overexpression or knockdown of a given gene on T helper cell differentiation and other primary human T cell functions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1759
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
310
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
30-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16516225-Blotting, Western,
pubmed-meshheading:16516225-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16516225-Cell Differentiation,
pubmed-meshheading:16516225-Electroporation,
pubmed-meshheading:16516225-Flow Cytometry,
pubmed-meshheading:16516225-H-2 Antigens,
pubmed-meshheading:16516225-Humans,
pubmed-meshheading:16516225-Immunomagnetic Separation,
pubmed-meshheading:16516225-Jurkat Cells,
pubmed-meshheading:16516225-Plasmids,
pubmed-meshheading:16516225-RNA Interference,
pubmed-meshheading:16516225-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16516225-STAT6 Transcription Factor,
pubmed-meshheading:16516225-Th1 Cells,
pubmed-meshheading:16516225-Th2 Cells,
pubmed-meshheading:16516225-Transfection
|
pubmed:year |
2006
|
pubmed:articleTitle |
Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation.
|
pubmed:affiliation |
Turku Centre for Biotechnology, Turku University and Abo Akademi University, Finland. johanna.tahvanainen@btk.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|